Guide · Updated March 2026

Fat Loss vs. Weight Loss on GLP-1s: Why Your Scale Is Lying to You

Clinical trials show 34-45% of weight lost on GLP-1 medications is lean mass (muscle and other non-fat tissue), not fat. In the STEP 1 semaglutide trial, lean mass accounted for 39-45% of total weight lost. Tirzepatide performed slightly better in SURMOUNT-1, with lean mass at about 34% of total loss. DEXA scans are the most accurate way to track whether you are losing fat or muscle.

Six months into Mounjaro, I was down 38 pounds. My doctor was thrilled. My clothes were falling off. And I was quietly convinced I was also losing a significant amount of muscle, because I looked softer than I expected to for someone who had lost that much weight.

So I booked a DEXA scan. The results were not what I feared, but they were not what I hoped for either. They were complicated. And they made me realize that the number on my bathroom scale was only telling a fraction of the story.

The distinction between fat loss and weight loss on GLP-1 medications is one of the most misunderstood topics in the space. This article breaks down what actually happens to your body composition on these drugs, what the clinical trials show about muscle loss, how I track my own progress with DEXA, and why optimizing for the scale alone is the wrong goal.

What “Weight Loss” Actually Measures

Your scale measures gravity’s pull on your total mass. That includes fat, muscle, bone, water, glycogen stores, the food currently in your digestive tract, and everything else. When the number drops, any combination of those components could be responsible.

This matters because not all weight loss is equal. Losing a pound of fat is metabolically very different from losing a pound of muscle. Fat is stored energy. Muscle is metabolically active tissue that burns calories at rest, supports movement, and protects your joints and bones as you age.

When people talk about wanting to lose weight, they almost universally mean they want to lose fat while keeping muscle. The scale cannot tell you whether you achieved that.

Why GLP-1s Complicate This Further

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) work primarily by suppressing appetite. You eat significantly less. A large caloric deficit is exactly what drives rapid weight loss on these drugs. The appetite suppression also comes with side effects that can make eating enough protein challenging, which matters for muscle preservation.

The problem is that rapid weight loss from any large caloric deficit, drug-induced or not, tends to come with meaningful lean mass loss alongside fat loss. Your body is not precise about what it burns when you’re in a steep deficit. It pulls from fat stores, yes. But it also pulls from muscle if the conditions are right.

The question for GLP-1 users is not whether you will lose some muscle. You probably will. The question is how much, how to minimize it, and whether the net body composition change is still favorable.

What the Clinical Trials Actually Found

The STEP 1 and SURMOUNT-1 trials included body composition measurements, so we have reasonably good data on this.

Semaglutide (STEP 1)

In the STEP 1 trial published in the New England Journal of Medicine in February 2021, participants on 2.4mg semaglutide lost an average of 14.9% of body weight over 68 weeks. What the headline numbers don’t tell you is where that weight came from.

Body composition analysis in STEP 1 showed that lean mass accounted for approximately 39 to 45% of the total weight lost. So for someone who lost 33.7 pounds on average, roughly 13 to 15 pounds of that was lean tissue. That is a meaningful amount.

Tirzepatide (SURMOUNT-1)

SURMOUNT-1, published in NEJM in July 2022, showed better body composition outcomes. At the 15mg dose, total body fat mass decreased by 33.9% while lean mass decreased by 10.9%. More importantly, the lean-to-fat ratio actually improved, meaning participants ended up with a better body composition than when they started despite losing lean mass in absolute terms.

The lean mass loss in SURMOUNT-1 was approximately 34% of total weight lost, which is somewhat better than the semaglutide figures from STEP 1.

Here is how those numbers compare side by side:

The takeaway is that tirzepatide appears to preserve lean mass somewhat better relative to fat lost, which aligns with why many people report looking and feeling leaner on Mounjaro compared to Wegovy even at similar weight loss numbers. That said, both drugs cause some lean mass loss. Neither is a free pass.

For a deeper comparison of how these two drugs perform overall, see our Mounjaro dosage guide.

My DEXA Results: Six Months on Mounjaro

I got my first DEXA scan about three months after starting Mounjaro, then another at the six-month mark. I am going to share the actual numbers because vague descriptions are useless. For the full breakdown including regional body composition data, see my complete DEXA scan results after 6 months on Mounjaro.

Baseline (before Mounjaro):

• Total weight: 247 lbs
• Body fat: 34.2% (84.5 lbs fat mass)
• Lean mass: 158.7 lbs
• Bone mineral content: ~3.8 lbs

At 3 months (down 19 lbs, on 7.5mg):

• Total weight: 228 lbs
• Body fat: 31.1% (70.9 lbs fat mass)
• Lean mass: 153.4 lbs
• Change: Lost 13.6 lbs fat, lost 5.3 lbs lean mass

So at three months, about 28% of my weight loss was lean mass. Better than the trial averages, but I was also lifting weights three times a week and hitting roughly 160-180g of protein per day. Without that, I suspect the lean mass loss would have been worse.

At 6 months (down 38 lbs total, on 10mg):

• Total weight: 209 lbs
• Body fat: 27.8% (58.1 lbs fat mass)
• Lean mass: 147.4 lbs
• Change from baseline: Lost 26.4 lbs fat, lost 11.3 lbs lean mass

Over six months, about 30% of my total weight loss was lean mass. The other 70% was fat. My body fat percentage dropped from 34.2% to 27.8%, which is a significant shift in actual body composition even though I lost some muscle.

The scale said I lost 38 pounds. The DEXA said I lost 26 pounds of fat and 11 pounds of muscle. Those are very different stories.

Why This Matters More Than You Think

Losing 11 pounds of muscle over six months is not catastrophic, especially given the concurrent fat loss. But it is worth understanding the downstream consequences.

Metabolic rate. Muscle burns more calories at rest than fat does. Lose a significant amount of lean mass and your resting metabolic rate drops. This is part of why people who lose weight through severe caloric restriction often regain it. Their bodies now burn fewer calories at baseline.

Body composition rebound risk. If you stop a GLP-1 and your appetite returns to baseline, but your metabolic rate is now lower than it was before you started, you are in a worse position than when you began. The regain tends to come back as fat, not muscle, which worsens your body composition further.

Functional strength. This is the one people underestimate. At six months on Mounjaro, I was noticeably weaker in the gym. Not dramatically, but my bench press dropped about 15 lbs from my pre-drug numbers even though I was training consistently. That is lean mass loss expressing itself as reduced capacity.

Long-term metabolic health. This is the goal behind the goal. GLP-1s are associated with cardiovascular risk reduction, better insulin sensitivity, and improved metabolic markers. Those benefits are real regardless of body composition changes. But maximizing fat loss while minimizing muscle loss gives you the best long-term metabolic foundation.

How to Shift the Equation Toward Fat Loss

You cannot completely prevent lean mass loss on a GLP-1-driven caloric deficit. But you can shift the ratio significantly. Here is what the evidence supports, plus what I actually do.

Resistance Training

This is the most important lever you have. Resistance training signals to your body that muscle is worth preserving. Without that signal, a caloric deficit pulls from both fat and muscle indiscriminately.

A 2024 analysis in Diabetes, Obesity and Metabolism (Neeland et al.) confirmed that exercise, particularly resistance exercise, substantially improves lean mass preservation in patients on GLP-1 medications. The effect is meaningful enough that skipping the gym while on these drugs is genuinely counterproductive if your goal is body composition rather than just scale weight.

I lift three days a week: upper/lower split, mostly compound movements. Not glamorous, but it worked. My lean mass loss over six months was below the trial averages, and I attribute most of that to the lifting.

For more on this topic, including specific protocols, see our guide on GLP-1s, exercise, and muscle.

Protein Intake

When calories drop, protein needs to stay high. The general guideline for preserving lean mass during a caloric deficit is 0.7 to 1.0 grams of protein per pound of target body weight. On GLP-1s, where appetite suppression can make it hard to eat enough of anything, getting adequate protein requires deliberate planning.

My approach: protein comes first at every meal. If I only have room for 400 calories at lunch, I make sure 150-180 of those calories are protein. Greek yogurt, cottage cheese, eggs, chicken, protein shakes when appetite is low. It is mechanical at this point.

Rate of Loss

Faster is not always better. Very rapid weight loss, the kind you might see in the first months at higher doses, correlates with higher rates of lean mass loss. If you have the option of titrating more slowly, it is worth considering from a body composition standpoint, even if the scale moves more slowly. If you hit a point where loss stalls completely, our Mounjaro plateau guide covers what to try before assuming the worst.

I pushed my dose from 5mg to 7.5mg at month two and the weight dropped fast but so did my lean mass numbers. Going from 7.5mg to 10mg at month five, I was more deliberate about my protein intake and training, and the lean mass loss rate slowed.

How to Actually Track Body Composition

The scale is not going to tell you any of this. Here are the options, roughly ranked by accuracy.

I use DEXA every 3 months and a tape measure weekly. The DEXA gives me actual data. The tape measure gives me directional feedback between scans so I know if I am trending the right way. If cost is a concern, our cheapest GLP-1 options guide covers how to minimize what you spend on the medication itself so you have budget for tracking tools like DEXA.

Home bioelectrical impedance scales like the Withings Body+ are not accurate enough for precise tracking, but they can be useful for spotting trends if you use them consistently under the same conditions (same time of day, same hydration state). Do not compare single readings. Compare 4-week averages.

What Numbers to Track

Beyond the scale, these are the metrics worth monitoring on a GLP-1:

• Body fat percentage. The main outcome. Are you losing fat as a proportion of your total mass?
• Lean mass in pounds. Are you losing muscle at a concerning rate?
• Waist circumference. Strongly correlated with visceral fat, which is the metabolically dangerous kind. This often drops faster than total weight.
• Waist-to-hip ratio. Another proxy for visceral fat distribution.
• Progress photos every 4 weeks. Tedious but useful. Pair with DEXA to understand what body composition shifts actually look like visually.

The Scale Does Get Some Things Right

To be fair, scale weight is not useless. It is easy to measure, consistent, and a reasonable proxy for direction of travel. If you are losing 2 pounds a week for months, something real is happening.

The problem is using it as your only metric, or treating it as a precise measure of fat loss. A 2-pound gain after a high-sodium weekend is not fat gain. A week with no scale movement while you are in a caloric deficit might reflect water retention or glycogen loading from a harder training week.

Body weight also fluctuates by 2 to 5 pounds across a single day based on food, water, and digestive contents. Weighing yourself every morning and treating each reading as meaningful is a reliable way to make yourself miserable.

My approach: weigh daily, record it, and look at the 7-day rolling average. Individual days are noise. Trends over 3 to 4 weeks are signal.

A Note on GLP-1 Discontinuation and Body Composition

This is where body composition tracking becomes especially important, and it connects to a genuine concern about these medications.

The evidence is clear that most people regain weight after stopping GLP-1s. The STEP 1 extension study showed participants regaining roughly two-thirds of their lost weight within a year of discontinuation. That regain is primarily fat, not muscle. So your post-drug body composition can end up worse than your pre-drug composition, even at a similar weight.

This is not a reason to avoid GLP-1s. The cardiovascular and metabolic benefits during treatment are real and significant. But it is a reason to think carefully about long-term strategy, including whether you plan to stay on the medication indefinitely, and what your plan is for maintaining muscle through diet and training regardless.

If you are evaluating whether to start a GLP-1 and want to compare costs and providers, our provider directory has current pricing and what each service includes.

You can also check our insurance coverage guide if you are trying to figure out whether your plan will cover any of this, because the cost math changes significantly if you have coverage. Medicare beneficiaries should see our Medicare GLP-1 coverage guide for the latest on the $50/month program.

The Bottom Line

The fat loss vs. weight loss distinction on GLP-1s is not academic. It determines whether your body composition actually improves, whether your metabolism is in a better position after treatment, and whether the results you see are real or partly illusory.

The trials are clear that tirzepatide and semaglutide both cause some lean mass loss alongside fat loss, roughly 34 to 45% of total weight lost comes from lean tissue depending on the drug and the individual. My personal DEXA data landed at about 30% lean mass loss over six months, which I attribute to consistent resistance training and high protein intake.

If you are on a GLP-1 and only tracking the scale, you are missing the most important information. Get a DEXA scan. Lift weights. Hit your protein target. The scale will keep moving either way. What matters is what you are actually losing.

Frequently Asked Questions

Do GLP-1 medications cause muscle loss?

Yes, to varying degrees. Clinical trials show that roughly 34 to 45% of total weight lost on GLP-1s comes from lean mass rather than fat. Resistance training and adequate protein intake (0.7-1.0g per pound of target body weight) can substantially reduce this. Tirzepatide appears to preserve lean mass slightly better than semaglutide based on available trial data.

Is fat loss vs. weight loss on GLP-1s something my doctor will track?

Probably not unless you ask. Most clinical monitoring focuses on scale weight, waist circumference, and metabolic labs. DEXA scans are rarely ordered as standard of care for GLP-1 patients. If body composition matters to you, you will likely need to seek out and pay for DEXA scans independently. Many imaging centers offer them for $50 to $150 without a prescription.

Why does the scale sometimes not move even when I am losing fat?

Water retention, muscle glycogen, hormonal fluctuations, and digestive contents all affect the scale independently of fat loss. Starting a resistance training program often causes the body to retain water in muscles as they adapt, which can mask fat loss on the scale for weeks. This is why DEXA or tape measurements give better information than daily weigh-ins alone.

How much muscle loss is too much on a GLP-1?

There is no universal threshold, but losing more than 40% of your total weight loss as lean mass is generally considered unfavorable from a metabolic standpoint. If your body fat percentage is not improving even as the scale drops, that is a sign your lean-to-fat loss ratio needs attention. Regular DEXA scans every 3 to 6 months will catch this early.

Can you build muscle while on a GLP-1?

It is difficult to build muscle in a significant caloric deficit, which is the situation most GLP-1 users are in. The more realistic goal is minimizing lean mass loss rather than adding new muscle during active weight loss. Once you reach a stable weight and increase calories back toward maintenance, building muscle becomes more feasible, and your body composition at that point will reflect how well you protected lean mass during the loss phase.

Related

Guides:

• Cheapest GLP-1 Online · Insurance Coverage · Side Effects
• Mounjaro Dosage Guide · Oral vs Injectable · Exercise and Muscle
• DEXA Scan Results on Mounjaro · Mounjaro Plateau Guide · Medicare GLP-1 Coverage

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides